Results 111 to 120 of about 2,830 (159)

Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype. [PDF]

Am J Case Rep
Cullufi P, Velmishi V, Dervishi E, Tomori S, Hoxha G, Jazexhiu-Postoli E, Basha E, Tako AK, Tabaku M.   +8 more
europepmc   +1 more source

A novel peptide-based strategy to enhance GBA1 expression for treating Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Kim H, Na J, Ryu HG, Lee E, Park H, Park H, Nam Y, Jeong GH, Pyo IH, Choi JH, Nah J, Jang SM, Song JH, Cho SJ, Kim S.   +14 more
europepmc   +1 more source

The relationship between neuropsychiatric dimensions and markers of Parkinson's disease risk in the UK Biobank. [PDF]

NPJ Parkinsons Dis
Attaallah B, Waters S, Marshall C, Noyce A.   +3 more
europepmc   +1 more source

p.N370S <i>GBA1</i> Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson's Disease. [PDF]

Int J Mol Sci
Usenko TS, Kopytova AE, Izyumchenko AD, Kulabukhova DG, Silantyev AS, Kazakova VD, Basharova KS, Bezrukova AI, Garaeva LA, Pichkur EB, Artynyuk AV, Miliukhina IV, Timofeeva AA, Miroshnikova VV, Naryzhny SN, Emelyanov AK, Zakharzhevskaya NB, Konevega AL, Shtam TA, Pchelina SN.   +19 more
europepmc   +1 more source

Editorial: Exploring gut neuroimmunology: focus on the enteric nervous system in health and disease. [PDF]

Front Neurosci
Otero-Losada M, Bhave S, Dora D.
europepmc   +1 more source

Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variants. [PDF]

NPJ Parkinsons Dis
Slingerland S, de Meyer EKR, van der Horn HJ, Carli G, Slomp AC, d'Angremont E, Boertien JM, Goethals I, Meles SK, van der Zee S, van Laar T.   +10 more
europepmc   +1 more source

WES-Based Screening of a Swedish Patient Series with Parkinson's Disease. [PDF]

Genes (Basel)
Kafantari E, Atterling Brolin K, Wallenius J, Swanberg M, Puschmann A.   +4 more
europepmc   +1 more source

Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation. [PDF]

NPJ Parkinsons Dis
Bove F, Genovese D, De Biase A, Albanese A, Antonini A, Artusi CA, Avanzino L, Avenali M, Baldelli L, Calandra-Buonaura G, Cani I, Casasoli N, Cavallieri F, Cilia R, Cocco A, Colucci F, Di Biasio F, D'Onofrio V, Eleopra R, Fioravanti V, Giannini G, Golfre' Andreasi N, Guerra A, Imbalzano G, Izzo A, Ledda C, Liccari M, Lopiano L, Malaguti MC, Minardi R, Mitrotti P, Romito LM, Valente EM, Valzania F, Zangaglia R, Calabresi P, Piano C, Bentivoglio AR, Italian PARKNET Study.   +38 more
europepmc   +1 more source

Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3. [PDF]

Ann Med Surg (Lond)
Saif M, Nasir A, Shafique S, Fatima M, Talha M.   +4 more
europepmc   +1 more source

Decreased SNCA expression in whole-blood RNA analysis of Parkinson's disease adjusting for neutrophils. [PDF]

NPJ Parkinsons Dis
Xu KY, Violich I, Hutchins E, Alsop E, Nalls MA, Moore A, Blauwendraat C, Raphael Gibbs J, Cookson MR, Van Keuren-Jensen K, Craig DW.   +10 more
europepmc   +1 more source